• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝病急性发作的定义与分类

Definition and classification of acute-on-chronic liver diseases.

作者信息

Zhang Yuan-Yao, Meng Zhong-Ji

机构信息

Postgraduate Training Basement of Jinzhou Medical University, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.

Institute of Biomedical Research, Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.

出版信息

World J Clin Cases. 2022 May 26;10(15):4717-4725. doi: 10.12998/wjcc.v10.i15.4717.

DOI:10.12998/wjcc.v10.i15.4717
PMID:35801045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9198886/
Abstract

Patients with chronic liver diseases (CLDs) develop acute liver injury and/or acute decompensation under the attack of various precipitants and present with significantly elevated alanine aminotransferase and/or total bilirubin levels, liver failure, or acute decompensation of liver cirrhosis, which is called acute-on-CLD (AoCLD). AoCLD accounts for the majority of patients hospitalized in the Department of Hepatology or Infectious Diseases. AoCLD is complicated by various clinical types, the severity of the disease, and may pose a high risk of death. To date, the definition of AoCLD is still vague, and a consensus concept of the clinical classification is lacking. This review aimed to define the concept and clinical types of AoCLD based on related studies and the literature.

摘要

慢性肝病(CLD)患者在各种诱因的作用下发生急性肝损伤和/或急性失代偿,表现为丙氨酸转氨酶和/或总胆红素水平显著升高、肝衰竭或肝硬化急性失代偿,这被称为慢性肝病急性发作(AoCLD)。AoCLD占肝病科或感染科住院患者的大多数。AoCLD有多种临床类型,病情严重,可能导致高死亡风险。迄今为止,AoCLD的定义仍不明确,缺乏临床分类的共识概念。本综述旨在根据相关研究和文献确定AoCLD的概念和临床类型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b96/9198886/32cf22ef1b34/WJCC-10-4717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b96/9198886/32cf22ef1b34/WJCC-10-4717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b96/9198886/32cf22ef1b34/WJCC-10-4717-g001.jpg

相似文献

1
Definition and classification of acute-on-chronic liver diseases.慢性肝病急性发作的定义与分类
World J Clin Cases. 2022 May 26;10(15):4717-4725. doi: 10.12998/wjcc.v10.i15.4717.
2
Characterization of acute-on-chronic liver diseases: A multicenter prospective cohort study.慢性肝病急性发作的特征:一项多中心前瞻性队列研究。
World J Hepatol. 2024 May 27;16(5):809-821. doi: 10.4254/wjh.v16.i5.809.
3
Lower platelet counts were associated with 90-day adverse outcomes in acute-on-chronic liver disease patients.血小板计数较低与慢加急性肝衰竭患者 90 天不良结局相关。
Ann Palliat Med. 2021 Sep;10(9):9342-9353. doi: 10.21037/apm-21-1019. Epub 2021 Aug 13.
4
Increased turnover of Gc-globulin in patients with hepatic encephalopathy.肝性脑病患者中Gc球蛋白周转率增加。
Scand J Gastroenterol. 2001 Sep;36(9):998-1003. doi: 10.1080/003655201750305558.
5
Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China.在中国一项前瞻性多中心研究中,急、慢性肝病患者血清钠变异的流行率及其临床意义。
Hepatol Int. 2022 Feb;16(1):183-194. doi: 10.1007/s12072-021-10282-8. Epub 2022 Jan 17.
6
Cell death markers in patients with cirrhosis and acute decompensation.肝硬化和急性失代偿患者的细胞死亡标志物。
Hepatology. 2018 Mar;67(3):989-1002. doi: 10.1002/hep.29581. Epub 2018 Jan 24.
7
Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation.细胞死亡标志物在肝硬化急性失代偿患者中的诊断和预后意义。
PLoS One. 2022 Feb 17;17(2):e0263989. doi: 10.1371/journal.pone.0263989. eCollection 2022.
8
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).既往肝脏疾病与 SARS-CoV-2 感染患者的不良结局相关;APCOLIS 研究(亚太肝脏研究学会 COVID-19 肝脏损伤谱研究)。
Hepatol Int. 2020 Sep;14(5):690-700. doi: 10.1007/s12072-020-10072-8. Epub 2020 Jul 4.
9
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.肝脏硬度与慢性肝病患者的失代偿、肝癌和死亡风险相关:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1573-84.e1-2; quiz e88-9. doi: 10.1016/j.cgh.2013.07.034. Epub 2013 Aug 15.
10
Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol.细胞疗法对慢性肝病和慢加急性肝衰竭患者的临床疗效:一项系统评价方案
Syst Rev. 2016 Jun 14;5:100. doi: 10.1186/s13643-016-0277-6.

引用本文的文献

1
Roles of inflammatory cytokines in the pathogenesis of hepatitis B virus-related acute-on-chronic liver failure and CAR-T therapy.炎症细胞因子在乙型肝炎病毒相关慢加急性肝衰竭发病机制及嵌合抗原受体T细胞(CAR-T)疗法中的作用
Virol J. 2025 Aug 16;22(1):281. doi: 10.1186/s12985-025-02868-7.
2
Characterization of acute-on-chronic liver diseases: A multicenter prospective cohort study.慢性肝病急性发作的特征:一项多中心前瞻性队列研究。
World J Hepatol. 2024 May 27;16(5):809-821. doi: 10.4254/wjh.v16.i5.809.
3
An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases.

本文引用的文献

1
Liver cirrhosis.肝硬化。
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
2
Lower platelet counts were associated with 90-day adverse outcomes in acute-on-chronic liver disease patients.血小板计数较低与慢加急性肝衰竭患者 90 天不良结局相关。
Ann Palliat Med. 2021 Sep;10(9):9342-9353. doi: 10.21037/apm-21-1019. Epub 2021 Aug 13.
3
Impact of Hepatic Encephalopathy on Clinical Characteristics and Adverse Outcomes in Prospective and Multicenter Cohorts of Patients With Acute-on-Chronic Liver Diseases.
过氧化物酶体增殖物激活受体在肝脏疾病中的作用概述
J Clin Transl Hepatol. 2023 Dec 28;11(7):1542-1552. doi: 10.14218/JCTH.2023.00334. Epub 2023 Nov 15.
肝性脑病对慢性肝病急性发作患者前瞻性多中心队列临床特征及不良结局的影响
Front Med (Lausanne). 2021 Aug 2;8:709884. doi: 10.3389/fmed.2021.709884. eCollection 2021.
4
Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease".“代偿期晚期慢性肝病”概念时代肝纤维化分期的血清生物标志物
J Clin Med. 2021 Jul 28;10(15):3340. doi: 10.3390/jcm10153340.
5
Quantitative serum HBV markers in predicting phases of natural history of chronic HBV infection.定量血清 HBV 标志物在预测慢性 HBV 感染自然史阶段中的作用。
J Virol Methods. 2021 Oct;296:114226. doi: 10.1016/j.jviromet.2021.114226. Epub 2021 Jul 1.
6
Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure.新型冠状病毒肺炎合并急性或亚急性肝衰竭患者的特征及院内结局
Dig Liver Dis. 2021 Sep;53(9):1069-1070. doi: 10.1016/j.dld.2021.05.027. Epub 2021 May 31.
7
Comparing CLIF-C ACLF, CLIF-C ACLF, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience.单中心重症监护病房经验:比较慢性肝衰竭急性发作患者的CLIF-C ACLF、CLIF-C ACLF和CLIF-C ACLF-D预后评分
J Pers Med. 2021 Jan 29;11(2):79. doi: 10.3390/jpm11020079.
8
World Gastroenterology Organisation classification and a new type-based prognostic model for hepatitis B virus-related acute-on-chronic liver failure.世界胃肠病组织分类和基于新型预后模型的乙型肝炎病毒相关慢加急性肝衰竭。
Clin Res Hepatol Gastroenterol. 2021 May;45(3):101548. doi: 10.1016/j.clinre.2020.09.009. Epub 2020 Oct 22.
9
Effect of probiotic Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults.食用益生菌Dad-13粉对超重成年人肠道微生物群和肠道健康的影响。
World J Gastroenterol. 2021 Jan 7;27(1):107-128. doi: 10.3748/wjg.v27.i1.107.
10
Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study.队列特征描述:一项中国慢加急性肝衰竭(CATCH-LIFE)研究的多中心前瞻性验证队列研究。
BMJ Open. 2021 Jan 8;11(1):e037793. doi: 10.1136/bmjopen-2020-037793.